Quantbot Technologies’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.9K Buy
+2,646
New +$42.3K ﹤0.01% 1658
2024
Q2
Sell
-20,500
Closed -$103K 1426
2024
Q1
$103K Buy
+20,500
New +$139K 0.01% 1164
2022
Q4
Sell
-29,600
Closed -$222K 1664
2022
Q3
$222K Buy
+29,600
New +$256K 0.02% 848
2017
Q2
Sell
-37,554
Closed -$275K 1100
2017
Q1
$275K Buy
+37,554
New +$173K 0.03% 556

Other funds holding AUPH

Quantbot Technologies's AUPH Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 2,646 shares worth $44.9K. The stake represents ﹤0.01% of the portfolio and ranks #1658 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in AUPH as recently as Q1 2024.

Quantbot Technologies first reported a position in AUPH in Q1 2017 and has held it in 4 quarters since. The position peaked at $275K in Q1 2017. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Quantbot Technologies held 2,646 shares of Aurinia Pharmaceuticals worth $44.9K as of Q2 2026.
  • Aurinia Pharmaceuticals was a new Quantbot Technologies position in Q2 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1658 holding.
  • Quantbot Technologies first reported a position in Aurinia Pharmaceuticals in Q1 2017 and has held it in 4 quarters since.
  • Quantbot Technologies's Aurinia Pharmaceuticals position peaked at $275K in Q1 2017.
  • 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.